A prominent Democratic U.S. senator is slamming pharmaceutical companies for opposing marijuana legalization.

"To them it's competition for chronic pain, and that's outrageous because we don't have the crisis in people who take marijuana for chronic pain having overdose issues," Sen. Kirsten Gillibrand of New York said. "It's not the same thing. It's not as highly addictive as opioids are."

"On the federal level, we really need to say it is a legal drug you can access if you need it," she said.

Click here to read the complete article

Tom Angell ~ Forbes.com ~